We are live on ! Find out more
AIM

Alambic Investment Management Portfolio holdings

AUM $9.12M
1-Year Est. Return 34.55%
This Fund
S&P 500
This Quarter Est. Return
+8.18%
1 Year Est. Return
+34.55%
3 Year Est. Return
+47.56%
5 Year Est. Return
+107.87%
10 Year Est. Return
AUM
$564M
AUM Growth
+$138M
Cap. Flow
+$110M
Cap. Flow %
19.56%
Top 10 Hldgs %
8.29%
Holding
645
New
142
Increased
248
Reduced
144
Closed
83

Sector Composition

Rank Sector Weight
1 Industrials 21.14%
2 Consumer Discretionary 18.77%
3 Technology 16.79%
4 Healthcare 9.28%
5 Communication Services 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLKN icon
326
MillerKnoll
MLKN
$1.63B
$513K 0.09%
15,000
+2,600
+21% +$81K
FUEL
327
DELISTED
Rocket Fuel Inc.
FUEL
$513K 0.09%
299,809
+89,818
+43% +$188K
RBBN icon
328
Ribbon Communications
RBBN
$358M
$512K 0.09%
81,200
-42,500
-34% -$279K
BLDR icon
329
Builders FirstSource
BLDR
$8.03B
$510K 0.09%
+46,500
New +$504K
ASNA
330
DELISTED
Ascena Retail Group, Inc.
ASNA
$509K 0.09%
4,115
+1,205
+41% +$146K
HURC icon
331
Hurco Companies Inc
HURC
$142M
$508K 0.09%
15,358
-2,227
-13% -$66.4K
VIAB
332
DELISTED
Viacom Inc. Class B
VIAB
$498K 0.09%
14,200
-19,400
-58% -$713K
OME
333
DELISTED
Omega Protein
OME
$498K 0.09%
19,900
+9,400
+90% +$222K
TVTX icon
334
Travere Therapeutics
TVTX
$5.73B
$496K 0.09%
26,200
-500
-2% -$10.2K
FRAN
335
DELISTED
Francesca's Holdings Corporation
FRAN
$494K 0.09%
2,283
+333
+17% +$69.2K
MNTA
336
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$485K 0.09%
32,202
-1,700
-5% -$22.5K
MED icon
337
Medifast
MED
$130M
$483K 0.09%
11,600
-3,650
-24% -$147K
ESND
338
DELISTED
Essendant Inc.
ESND
$483K 0.09%
+23,100
New +$439K
EA
339
DELISTED
Electronic Arts
EA
$480K 0.09%
6,100
-400
-6% -$32.2K
CHRS icon
340
Coherus Oncology
CHRS
$188M
$479K 0.09%
+17,000
New +$476K
EMR icon
341
Emerson Electric
EMR
$91.6B
$479K 0.09%
8,600
+4,900
+132% +$264K
CHK
342
DELISTED
Chesapeake Energy Corporation
CHK
$477K 0.08%
340
+9
+3% +$11.8K
ACLS icon
343
Axcelis
ACLS
$4.13B
$475K 0.08%
32,612
-8,204
-20% -$112K
UTEK
344
DELISTED
Ultratech Inc.
UTEK
$475K 0.08%
19,800
+7,100
+56% +$162K
GPRE icon
345
Green Plains
GPRE
$1.09B
$471K 0.08%
16,900
-3,100
-16% -$82.5K
PPG icon
346
PPG Industries
PPG
$25.8B
$469K 0.08%
+4,950
New +$472K
RUSHA icon
347
Rush Enterprises Class A
RUSHA
$9.47B
$463K 0.08%
32,659
+4,084
+14% +$50.5K
FLXS icon
348
Flexsteel Industries
FLXS
$305M
$461K 0.08%
7,475
+1,425
+24% +$74K
RIGL icon
349
Rigel Pharmaceuticals
RIGL
$770M
$454K 0.08%
19,061
+2,310
+14% +$66.2K
VRA icon
350
Vera Bradley
VRA
$95.3M
$453K 0.08%
+38,676
New +$532K

Similar funds

Alambic Investment Management's Q4 2016 Portfolio in Review

As of Q4 2016, Alambic Investment Management held 645 positions worth $564M, up 32% from $425M the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

Alambic Investment Management deployed $110M of net new capital in Q4 2016, opening 142 new positions and adding to 248 existing holdings. Its largest new stake was Chemours: 89,400 shares worth $1.98M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Mentor Graphics Corp, an estimated $1.35M trimmed.

  • Alambic Investment Management's largest Q4 2016 buy was Chemours: 89,400 shares worth $1.98M.
  • Alambic Investment Management added most to Lumen in Q4 2016, an estimated $3.87M increase.
  • Alambic Investment Management's biggest Q4 2016 reduction was Mentor Graphics Corp, cutting an estimated $1.35M.
  • Alambic Investment Management fully exited Monsanto Co in Q4 2016, selling an estimated $2.58M.
  • Alambic Investment Management's ten largest holdings make up 8.3% of its $564M portfolio in Q4 2016.
  • Alambic Investment Management opened 142 new positions and closed 83 in Q4 2016.
  • Alambic Investment Management's portfolio value rose 32% quarter-over-quarter to $564M.

Based on Alambic Investment Management's 13F filing for Q4 2016, filed 3 Feb 2017.